Skip to main content

Table 3 Serum Osteopontin and Osteoprotegerin in relation to different parameters in RA (n = 20)

From: Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease

 

(n = 20)

OPG

P

OPN

P

Mean ± SD.

Mean ± SD.

RF (< 15.9IU/ml)

Negative

2

60.50 ± 85.56

0.753

2.65 ± 0.35

0.753

Positive

18

153.15 ± 384.64

3.77 ± 4.43

ACPA (< 20U/ml)

Negative

3

42.47 ± 68.09

0.341

3.58 ± 2.58

0.289

Positive

17

161.78 ± 394.67

4.13 ± 3.48

Pain-VAS(0-10 mm)

5 - <7

4

14.58 ± 8.43

0.257

2.78 ± 2.39

0.344

7–10

16

176.21 ± 404.48

7.18 ± 7.92

PGA(0-100 mm)

0–50

4

14.58 ± 8.43

0.257

2.78 ± 2.39

0.344

> 50–100

16

176.21 ± 404.48

7.18 ± 7.92

  1. p values for Mann Whitney test for comparing between the two groups
  2. OPN: Osteopontin; OPG: Osteoprotegerin; RF: rheumatoid factor; ACPA: anti-citrullinated protein antibodies; VAS: Visual Analogue Scale; PGA: Patient global assessment